These data support the notion that elevated Ccl24 may contribute to severe airway allergy and maybe a useful biomarker to identify patients with severe asthma44 and supports the hypothesis that dysregulated TPL-2 in DCs may contribute to elevated Ccl24 in those with severe asthma; however, this needs to be tested. This evidence concerns the gene CCL24 and allergic respiratory disease.